Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 111 results found. Search for [ Novavax ]

Results 1 to 21 of 111
PTI
December 2, 2020
After playing a critical role in transporting essentials and medical supplies during the lockdown, SpiceXpress, has come forth to take up the responsibility of seamlessly transporting the vaccine through a specialised service called Spice Pharma Pro


Associated Press
December 2, 2020
The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe's deadliest COVID-19 outbreak


Reuters
December 2, 2020
It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing


Reuters
November 28, 2020
Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a 'very good' option


Reuters
November 28, 2020
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of \"cutting corners\", said Thomas Cueni, director-general of the IFPMA


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 23, 2020
Indian Council of Medical Research is working closely with SII for Covishield vaccine trials across 15 centres in India, and would also be funding the clinical trials in the country.


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


BusinessToday.In
November 13, 2020
On nations hoarding vaccine stocks to meet their requirements first, Dmitriev said it is not about vaccine nationalism and that India is an important partner


PB Jayakumar
November 12, 2020
Covishield has been developed at the Serum Institute of India's Pune laboratory with a master seed from Oxford University/Astra Zeneca. The vaccine made in the UK is currently being tested in large efficacy trials in UK, Brazil, South Africa and USA


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


Anshula Raj
November 12, 2020
Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India


Anwesha Madhukalya
November 10, 2020
Pfizer and BioNTech coronavirus vaccine: Logistical challenges such as ultra-low temperature storage could hamper the distribution plans not only in developing nations like India but also in advanced countries like the US


BusinessToday.In
November 5, 2020
Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses


BusinessToday.In
November 4, 2020
India has vaccine deals with Serum Institute of India that is manufacturing doses of the University of Oxford-AstraZeneca vaccine as well as the candidate by Novavax


PTI
October 31, 2020
The UK is committed to ensuring that everyone at risk of SARS-CoV-2 infection, anywhere in the world, has access to a safe and effective vaccine, said Bingham


PB Jayakumar & Joe C Mathew
October 22, 2020
Serum has floated a new company Serum Institute Life Sciences (SILS) that will exclusively focus on developing, producing and supplying pandemic vaccines


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


Reuters
October 14, 2020
While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PAGES 1 OF 6  12345